FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa. - Wikidata - awgldk - TriplyDB

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

http://www.wikidata.org/entity/Q54733425

about

SLC34A3 mutations in patients with hereditary hypophosphatemic rickets with hypercalciuria predict a key role for the sodium-phosphate cotransporter NaPi-IIc in maintaining phosphate homeostasis Hereditary hypophosphatemic rickets with hypercalciuria is caused by mutations in the sodium-phosphate cotransporter gene SLC34A3.FGF23-mediated regulation of systemic phosphate homeostasis: is Klotho an essential player?Miscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho)Vitamin D and the kidney FGF23 and Phosphate Wasting Disorders Regulation and function of the FGF23/klotho endocrine pathways Cardiovascular Risk Factors and Chronic Kidney Disease-FGF23: A Key Molecule in the Cardiovascular Disease Deletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho-/- mice A potential link between phosphate and aging--lessons from Klotho-deficient mice Fibroblast Growth Factor-23-A Potential Uremic Toxin Dysregulation of phosphate metabolism and conditions associated with phosphate toxicity Recent advances in the renal-skeletal-gut axis that controls phosphate homeostasis Genetic evidence of serum phosphate-independent functions of FGF-23 on bone Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing Parathyroidectomy The parathyroid is a target organ for FGF23 in rats FGF23 deficiency leads to mixed hearing loss and middle ear malformation in mice.α-Klotho expression determines nitric oxide synthesis in response to FGF-23 in human aortic endothelial cells Mineral metabolism and aging: the fibroblast growth factor 23 enigma.FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23 Association of serum levels of FGF23 and α-Klotho with glomerular filtration rate and proteinuria among cardiac patients.Relationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney Disease Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia.Cellular ATP synthesis mediated by type III sodium-dependent phosphate transporter Pit-1 is critical to chondrogenesis Recent advances in renal phosphate handling.Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation Calcium-deficiency assessment and biomarker identification by an integrated urinary metabonomics analysis.Initial FGF23-mediated signaling occurs in the distal convoluted tubule FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues.Molecular regulation of phosphate metabolism by fibroblast growth factor-23-klotho system Evaluation of a method for fibroblast growth factor-23: a novel biomarker of adverse outcomes in patients with renal disease.FGF-23/Klotho signaling is not essential for the phosphaturic and anabolic functions of PTH.Chronic high fructose intake reduces serum 1,25 (OH)2D3 levels in calcium-sufficient rodents.Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism.Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo Fibroblast growth factor 23 regulates renal 1,25-dihydroxyvitamin D and phosphate metabolism via the MAP kinase signaling pathway in Hyp mice Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals.FGF23 in skeletal modeling and remodeling.

P2860

Q24299058-3C2348FF-86C7-4EBE-B327-D750407B7DF3 Q24540520-6AA84E4C-2CBF-4C6A-A15A-60FB3118CE16 Q24653541-F0F1F33E-9ABE-4EE1-88C6-65E9BE359266 Q26827280-E7D5A1E5-ACDF-4EE6-AEA8-53ED596C2D02 Q26849921-862512E3-6539-43FC-A109-923780459ED1 Q26851904-FC74E26C-D8A5-4391-B8FD-DB2D3EA24D31 Q26860470-583E8CCB-3F93-439B-ADF8-44D9EDE42B3A Q27024043-CEE709FF-298D-4AA2-837A-846B49FA610D Q27333726-D1D0489F-E5A3-4F87-86ED-DF76E393340B Q27687316-11787995-A801-4817-BCDB-3FCBFF184815 Q28075648-DBE2BD66-9DDE-4E15-A22D-B7AF6F297B0D Q28085476-0E5F1930-BC36-4332-A68E-6C22EAB496C6 Q28301682-7F16A3A5-4F97-42A4-9A9A-F2D573D13DEF Q28473286-601034FC-58B7-454A-989D-BB9E32F0190E Q28507303-C703BA81-5EAB-4299-9A9B-0837FB10B678 Q28546638-398BD949-B9D1-4B82-8EDF-F52AF5CAB66E Q28572613-62AC2800-3860-4C3B-926F-9BCA65070D8D Q30430229-C73C5046-A5B9-49A0-A1FF-E22FF59E6E29 Q33626706-9AD6B253-6F8C-4F68-979C-89EDB96139E9 Q33982618-DB24B5B4-A387-4A76-81F6-84360E800EFA Q34017992-F7C030A7-F4DD-4731-8FB7-D0371BDF1F74 Q34075026-26E21152-B09F-409C-9097-E07D13CDAB0F Q34204949-D7149084-82F1-4E24-A8C8-6DB9FFD163BD Q34479134-BD6E8486-1889-4BCD-A056-497EBE01C2DC Q34480642-C0DE198E-DBDE-46DF-85A8-1FB32EF085FF Q34509607-98DB1C9A-6071-45A3-9D16-031C69232D85 Q34631794-375B1472-1A74-4672-9835-3A6BC0445F00 Q34632352-5EA192FF-65F5-4C4A-B551-7A56C1F6AE98 Q34640062-63CABDCE-A67E-4FEA-AAC7-665A0595A8EA Q34695191-019E505A-9999-46AC-A810-7D85F5A5256A Q34982729-E94C1FF5-30E3-4840-B976-E84AD9383ABB Q35059924-13F968A2-2B3C-47AD-9C4F-C240DBC9C0D7 Q35075064-ECD4250E-D616-4A81-8AE6-60A5ADA3001F Q35129687-3A6C768F-6D07-45CA-8875-9135FBCE4374 Q35144277-CFD0FBDA-752C-4897-BF28-0B4FECA3B8A1 Q35151453-DF39E413-8504-4540-B344-AE21791A10E4 Q35196515-4990F483-FA09-45CE-9721-40CEFFFC4BDB Q35538411-8ECA6117-DEC1-4A34-81AC-0B9B12F1878F Q35569891-F7F1D384-3893-4A6B-8B36-EC1801720C2C Q35707031-371E43E7-5E35-496E-A5BC-ADA91285C720

P2860

FGF-23 transgenic mice demonstrate hypophosphatemic rickets with reduced expression of sodium phosphate cotransporter type IIa.

http://www.wikidata.org/entity/Q54733425

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

FGF-23 transgenic mice demonst ...... sphate cotransporter type IIa.

@en

FGF-23 transgenic mice demonst ...... sphate cotransporter type IIa.

@nl

type

label

FGF-23 transgenic mice demonst ...... sphate cotransporter type IIa.

@en

FGF-23 transgenic mice demonst ...... sphate cotransporter type IIa.

@nl

prefLabel

FGF-23 transgenic mice demonst ...... sphate cotransporter type IIa.

@en

FGF-23 transgenic mice demonst ...... sphate cotransporter type IIa.

@nl

P1433

Q54733425-8FC0142F-4DD8-4BAF-986D-DF29FFDF242B

P1476

Q54733425-D060F889-0198-42FC-9378-AB4D45E0BC2A

P2093

Q54733425-0E25C6CC-A6AC-4901-A91C-2D67EBBA932B

Q54733425-136F7DA6-508C-4B08-9AE8-78D2FD58AB50

Q54733425-18EDB70A-580E-4784-84E4-7E001996BFF5

Q54733425-4C5EC2D0-06B5-46F3-B10B-A7BCC7DC4298

Q54733425-5336792F-9A2C-4D23-A1C4-EEDE5A89C082

Q54733425-8D26A7F2-3CB8-47EE-8933-90C074E9090B

Q54733425-9ABDE829-C26E-43E6-A043-C841B6F9B588

Q54733425-B9F09301-0E10-43FF-B5CD-E68174BB1F12

Q54733425-D419523F-D210-4DBA-81D9-B87D203B4CBC

Q54733425-E9F14A4F-79A6-44FC-AE24-1108197608D6

P304

Q54733425-93FAE002-85BB-48E5-9B20-21C634B7EF44

P31

Q54733425-2F03ED75-A73C-4602-9316-046D9FF4AEBE

P356

Q54733425-E231E2DB-2DBB-4DD5-9995-E3D30B0FA909

P407

Q54733425-6C843A76-2024-4403-852F-BCA53F0E8976

P433

Q54733425-A7AF421E-34B6-48C7-A3CC-4EAC14F5E091

P478

Q54733425-BB267247-50FB-422E-8368-BD1D2023BB36

P577

Q54733425-D770241F-4DC7-4E63-9731-B632ABFA4294

P698

Q54733425-0054319C-E653-4CE5-A8BE-4455BF5A1BD8

P356

J.BBRC.2003.12.102

P1433

Biochemical and Biophysical Research Communications

P1476

FGF-23 transgenic mice demonst ...... sphate cotransporter type IIa.

@en

P2093

Hisashi Hasegawa

http://www.w3.org/2001/XMLSchema#string

Itaru Urakawa

http://www.w3.org/2001/XMLSchema#string

Rieko Hino

http://www.w3.org/2001/XMLSchema#string

Seiji Fukumoto

http://www.w3.org/2001/XMLSchema#string

Takashi Shimada

http://www.w3.org/2001/XMLSchema#string

Takashi Yoneya

http://www.w3.org/2001/XMLSchema#string

Takeyoshi Yamashita

http://www.w3.org/2001/XMLSchema#string

Toshiro Fujita

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Takeuchi

http://www.w3.org/2001/XMLSchema#string

Yuji Yamazaki

http://www.w3.org/2001/XMLSchema#string

P304

409-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBRC.2003.12.102

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

314

http://www.w3.org/2001/XMLSchema#string

P577

2004-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14733920

http://www.w3.org/2001/XMLSchema#string